Carnick & Kubik’s Bausch Health BHC Stock Holding History

Carnick & Kubik’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$297K	Sell	11,293 -9,000	-44%	-$666K	0.09%	270
2015 Q4	$2.06M	Sell	20,293 -3,500	-15%	-$393K	1.32%	12
2015 Q3	$4.24M	Sell	23,793 -1,500	-6%	-$350K	2.97%	2
2015 Q2	$5.62M	Sell	25,293 -1,400	-5%	-$310K	4.59%	1
2015 Q1	$5.3M	Sell	26,693 -500	-2%	-$88.7K	4.42%	1
2014 Q4	$3.89M	Sell	27,193 -1,500	-5%	-$202K	3.31%	2
2014 Q3	$3.77M	Sell	28,693 -4,296	-13%	-$512K	3.46%	2
2014 Q2	$4.16M	Sell	32,989 -50	-0.2%	-$6.38K	4.15%	2
2014 Q1	$4.36M	Sell	33,039 -15	-0%	-$2.05K	4.15%	2
2013 Q4	$3.88M	Buy	+33,054	New	+$3.62M	3.51%	4
2013 Q3	–	Sell	-28,693	Closed	-$2.47M	–	87
2013 Q2	$2.47M	Buy	+28,693	New	+$2.26M	3.05%	3

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Carnick & Kubik's BHC Position: Q1 2016 in Review

Carnick & Kubik reduced its Bausch Health (BHC) stake by 44% in Q1 2016, selling an estimated $666K and leaving 11,293 shares worth $297K. The position accounts for 0.09% of the portfolio, ranked #270.

Carnick & Kubik first reported a position in BHC in Q2 2013 and has held it in 11 quarters since. The position peaked at $5.62M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Carnick & Kubik held 11,293 shares of Bausch Health worth $297K as of Q1 2016.
Carnick & Kubik sold 9,000 Bausch Health shares in Q1 2016, an estimated $666K.
Bausch Health made up 0.09% of Carnick & Kubik's portfolio in Q1 2016, its #270 holding.
Carnick & Kubik first reported a position in Bausch Health in Q2 2013 and has held it in 11 quarters since.
Carnick & Kubik's Bausch Health position peaked at $5.62M in Q2 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.